Ameriprise’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.49M Buy
192,799
+47,801
+33% +$1.03M ﹤0.01% 2506
2025
Q4
$2.9M Buy
144,998
+7,867
+6% +$154K ﹤0.01% 2798
2025
Q3
$2.5M Sell
137,131
-4,957
-3% -$96.6K ﹤0.01% 2893
2025
Q2
$2.85M Buy
142,088
+3,812
+3% +$73.3K ﹤0.01% 2752
2025
Q1
$2.51M Sell
138,276
-5,847
-4% -$105K ﹤0.01% 2775
2024
Q4
$2.5M Sell
144,123
-12,122
-8% -$233K ﹤0.01% 2797
2024
Q3
$3.02M Sell
156,245
-16,160
-9% -$298K ﹤0.01% 2697
2024
Q2
$2.83M Sell
172,405
-12,014
-7% -$186K ﹤0.01% 2702
2024
Q1
$2.81M Sell
184,419
-5,759
-3% -$90.5K ﹤0.01% 2699
2023
Q4
$3.05M Sell
190,178
-10,642
-5% -$149K ﹤0.01% 2656
2023
Q3
$2.61M Sell
200,820
-24,137
-11% -$313K ﹤0.01% 2693
2023
Q2
$2.86M Sell
224,957
-23,543
-9% -$295K ﹤0.01% 2696
2023
Q1
$2.8M Sell
248,500
-301
-0.1% -$3.65K ﹤0.01% 2679
2022
Q4
$3.3M Sell
248,801
-3,804
-2% -$50K ﹤0.01% 2552
2022
Q3
$2.93M Sell
252,605
-10,508
-4% -$144K ﹤0.01% 2582
2022
Q2
$3.88M Sell
263,113
-30,838
-10% -$505K ﹤0.01% 2454
2022
Q1
$5.69M Sell
293,951
-6,978
-2% -$125K ﹤0.01% 2336
2021
Q4
$5.19M Buy
300,929
+30,007
+11% +$511K ﹤0.01% 2434
2021
Q3
$4.53M Sell
270,922
-5,343
-2% -$79.9K ﹤0.01% 2455
2021
Q2
$3.71M Sell
276,265
-3,725
-1% -$46.6K ﹤0.01% 2651
2021
Q1
$3.35M Buy
279,990
+12,918
+5% +$156K ﹤0.01% 2628
2020
Q4
$3.31M Sell
267,072
-12,695
-5% -$137K ﹤0.01% 2533
2020
Q3
$2.92M Sell
279,767
-36,331
-11% -$462K ﹤0.01% 2442
2020
Q2
$4.42M Sell
316,098
-14,514
-4% -$197K ﹤0.01% 2147
2020
Q1
$3.89M Sell
330,612
-14,358
-4% -$190K ﹤0.01% 2072
2019
Q4
$4.88M Sell
344,970
-10,070
-3% -$124K ﹤0.01% 2246
2019
Q3
$3.74M Sell
355,040
-44,035
-11% -$527K ﹤0.01% 2364
2019
Q2
$5.81M Sell
399,075
-6,755
-2% -$95.7K ﹤0.01% 2143
2019
Q1
$5.69M Sell
405,830
-5,630
-1% -$91.2K ﹤0.01% 2135
2018
Q4
$7.18M Sell
411,460
-1,805
-0.4% -$29.3K ﹤0.01% 1865
2018
Q3
$6.3M Buy
413,265
+3,410
+0.8% +$49.1K ﹤0.01% 2196
2018
Q2
$5.66M Sell
409,855
-288,585
-41% -$4.32M ﹤0.01% 2159
2018
Q1
$11.6M Buy
698,440
+100,591
+17% +$1.55M 0.01% 1549
2017
Q4
$8.48M Buy
597,849
+20,234
+4% +$270K ﹤0.01% 1735
2017
Q3
$8.16M Buy
577,615
+20,160
+4% +$267K ﹤0.01% 1738
2017
Q2
$7.13M Buy
557,455
+147,765
+36% +$1.85M ﹤0.01% 1812
2017
Q1
$5.67M Buy
409,690
+20,664
+5% +$243K ﹤0.01% 1941
2016
Q4
$4.16M Buy
+389,026
New +$4.08M ﹤0.01% 2177
2014
Q4
Sell
-363,466
Closed -$6.21M 4049
2014
Q3
$6.21M Buy
363,466
+359,403
+8,846% +$8.26M ﹤0.01% 1878
2014
Q2
$121K Sell
4,063
-393
-9% -$9.43K ﹤0.01% 3517
2014
Q1
$111K Sell
4,456
-6,989
-61% -$205K ﹤0.01% 3469
2013
Q4
$336K Sell
11,445
-32,613
-74% -$954K ﹤0.01% 2981
2013
Q3
$1.45M Sell
44,058
-4,665
-10% -$145K ﹤0.01% 2567
2013
Q2
$1.51M Buy
+48,723
New +$1.31M ﹤0.01% 2477

Other funds holding INVA

Ameriprise's INVA Position: Q1 2026 in Review

Ameriprise increased its Innoviva (INVA) stake by 33% in Q1 2026, buying an estimated $1.03M and bringing the position to 192,799 shares worth $4.49M. The position accounts for ﹤0.01% of the portfolio, ranked #2506.

Ameriprise first reported a position in INVA in Q2 2013 and has held it in 44 quarters since. The position peaked at $11.6M in Q1 2018. 286 funds tracked by Wall St. Rank hold INVA as of Q1 2026.

  • Ameriprise held 192,799 shares of Innoviva worth $4.49M as of Q1 2026.
  • Ameriprise bought 47,801 Innoviva shares in Q1 2026, an estimated $1.03M.
  • Innoviva made up ﹤0.01% of Ameriprise's portfolio in Q1 2026, its #2506 holding.
  • Ameriprise first reported a position in Innoviva in Q2 2013 and has held it in 44 quarters since.
  • Ameriprise's Innoviva position peaked at $11.6M in Q1 2018.
  • 286 funds tracked by Wall St. Rank held Innoviva as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.